Fig. 2From: CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinomaSurvival analysis showed that overall and disease-free survival (DFS) were higher in the CD133 negative group than in the CD133 positive groupBack to article page